Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 14.3411.4511.2112.7717.14

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 14.34 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202414.34
Mar202311.45
Mar202211.21
Mar202112.77
Mar202017.14

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 14.34
25.24
Mar2023 11.45
2.14
Mar2022 11.21
-12.22
Mar2021 12.77
-25.50
Mar2020 17.14 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,983.1 Cr 1.3% 15.7% -0.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

1.3%

15.7%

-0.5%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses